SCHEMBL26291695

SCHEMBL26291695

C=CC(=O)OCOc1ccc2cc(-c3cccnc3CC)oc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.40
▸ KDM4E B2RXH2 5/20 0.40
▸ HPGD P15428 5/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ GAA P10253 4/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ GLA P06280 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ S1PR1 P21453 1/20 0.36
▸ S1PR3 Q99500 1/20 0.36
▸ APP P05067 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26291692 0.86 RAB9A (0.38) ALDH1A1KDM4EHPGDRAB9AGAA
SCHEMBL26291461 0.86 RAB9A (0.40) ALDH1A1KDM4EHPGDRAB9AGAA
SCHEMBL26292502 0.84 CYP3A4 (0.34) ALDH1A1KDM4EHPGDRAB9AGAA
SCHEMBL26291623 0.82 APP (0.37) ALDH1A1KDM4EHPGDRAB9AGAA
SCHEMBL26292178 0.82 RAB9A (0.42) ALDH1A1KDM4EHPGDRAB9AGAA
SCHEMBL23395563 0.81 KDM4E (0.34) ALDH1A1KDM4EHPGDRAB9AGAA
SCHEMBL26291480 0.81 PTPN1 (0.47) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL23395657 0.80 PTPN1 (0.49) ALDH1A1KDM4EHPGDRAB9AGAA
SCHEMBL26291464 0.79 HDAC6 (0.47) ALDH1A1KDM4EHPGDRAB9AGAA
SCHEMBL26291539 0.77 PTPN1 (0.58) ALDH1A1KDM4EHPGDRAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753387-B2 Compounds for optically active devices PDE6C, PDE6A, PDE6D ALDH1A1 388/4885KDM4E 3992/4885HPGD 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback